Total Payments
$9,463
2024 Payments
$4,639
Companies
42
Transactions
183
Medicare Patients
2,923
Medicare Billing
$655,396
Payment Breakdown by Category
Food & Beverage$5,239 (55.4%)
Consulting$2,655 (28.1%)
Other$1,100 (11.6%)
Education$409.52 (4.3%)
Travel$59.68 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,239 | 161 | 55.4% |
| Consulting Fee | $2,655 | 3 | 28.1% |
| Honoraria | $1,100 | 3 | 11.6% |
| Education | $409.52 | 15 | 4.3% |
| Travel and Lodging | $59.68 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | $3,100 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $1,427 | 11 | $0 (2024) |
| Foundation Medicine, Inc. | $619.23 | 16 | $0 (2019) |
| Merck Sharp & Dohme LLC | $417.65 | 17 | $0 (2024) |
| PFIZER INC. | $384.13 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $340.31 | 6 | $0 (2024) |
| Genentech USA, Inc. | $277.65 | 7 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $250.48 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $238.42 | 10 | $0 (2024) |
| GE HealthCare | $180.87 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,639 | 70 | Myriad Genetic Laboratories, Inc. ($2,938) |
| 2023 | $627.27 | 20 | Myriad Genetic Laboratories, Inc. ($146.09) |
| 2022 | $571.33 | 13 | GE HealthCare ($180.87) |
| 2021 | $551.97 | 17 | AstraZeneca Pharmaceuticals LP ($143.10) |
| 2020 | $231.16 | 8 | AMAG Pharmaceuticals, Inc. ($103.08) |
| 2019 | $1,591 | 19 | Janssen Biotech, Inc. ($1,190) |
| 2018 | $542.80 | 19 | Foundation Medicine, Inc. ($182.70) |
| 2017 | $708.71 | 17 | Foundation Medicine, Inc. ($407.63) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $39.44 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $37.87 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Genentech USA, Inc. | Itovebi (Biological), Polivy | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: BioOncology | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $21.26 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: BioOncology | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug), ERLEADA | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $58.22 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: Oncology | ||||||
| 08/27/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 751 | 1,477 | $212,726 | $125,065 |
| 2022 | 12 | 721 | 4,869 | $392,910 | $180,857 |
| 2021 | 16 | 850 | 6,035 | $434,800 | $211,166 |
| 2020 | 14 | 601 | 4,894 | $301,983 | $138,308 |
Total Patients
2,923
Total Services
17,275
Medicare Billing
$655,396
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 137 | 529 | $67,850 | $52,469 | 77.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 137 | 244 | $23,278 | $17,425 | 74.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 118 | $31,194 | $10,969 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 124 | 207 | $13,385 | $9,941 | 74.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 65 | 65 | $11,851 | $9,174 | 77.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 103 | $17,194 | $6,255 | 36.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 38 | $16,797 | $5,639 | 33.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 52 | $11,906 | $5,259 | 44.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 26 | $9,401 | $3,589 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $2,614 | $1,923 | 73.6% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 13 | 15 | $2,553 | $966.15 | 37.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 13 | $2,017 | $728.06 | 36.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 38 | $1,520 | $404.94 | 26.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 11 | $1,168 | $322.01 | 27.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 3,301 | $145,244 | $50,423 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 117 | 473 | $60,931 | $46,936 | 77.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 113 | 228 | $23,043 | $16,808 | 72.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 14 | 94 | $43,522 | $13,048 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 137 | 250 | $16,432 | $11,977 | 72.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 70 | 70 | $12,762 | $9,793 | 76.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 55 | $24,311 | $8,915 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 65 | $18,200 | $6,582 | 36.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 69 | $15,798 | $5,933 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 87 | $17,226 | $5,486 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $2,178 | $1,618 | 74.3% |
About Dr. Ethan Schram, M.D
Dr. Ethan Schram, M.D is a Internal Medicine healthcare provider based in Walnut Creek, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659320703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ethan Schram, M.D has received a total of $9,463 in payments from pharmaceutical and medical device companies, with $4,639 received in 2024. These payments were reported across 183 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($5,239).
As a Medicare-enrolled provider, Schram has provided services to 2,923 Medicare beneficiaries, totaling 17,275 services with total Medicare billing of $655,396. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Walnut Creek, CA
- Active Since 05/08/2006
- Last Updated 02/27/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659320703
Products in Payments
- MYRISK (Device) $2,507
- DARZALEX (Biological) $1,256
- FOUNDATIONONE (Device) $619.23
- PRECISETUMOR (Device) $577.07
- KEYTRUDA (Biological) $417.65
- Imbruvica (Drug) $250.48
- ENHERTU (Biological) $174.21
- NERLYNX (Drug) $123.73
- IBRANCE (Drug) $120.44
- TECENTRIQ (Biological) $117.63
- Enhertu (Drug) $108.40
- INTRAROSA (Drug) $103.08
- RYBREVANT (Drug) $99.50
- Da Vinci Surgical System (Device) $98.10
- Monarch Platform (Device) $97.76
- ENJAYMO (Biological) $93.15
- Phesgo (Biological) $84.76
- INLYTA (Drug) $78.54
- IMBRUVICA (Drug) $78.35
- FRUZAQLA (Drug) $77.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Walnut Creek
Anthony Padula, M.d, M.D
Internal Medicine — Payments: $804,141
Internal Medicine $804,141
Dr. Richard Chang, M.d, M.D
Internal Medicine — Payments: $295,804
Internal Medicine $295,804
Dr. Neal White, Md, MD
Internal Medicine — Payments: $224,225
Internal Medicine $224,225
Dr. Aditi Choudhry, M.d, M.D
Internal Medicine — Payments: $69,819
Internal Medicine $69,819
Dr. Andrew Dublin, Md, MD
Internal Medicine — Payments: $65,190
Internal Medicine $65,190
Dr. Bhavna Malik, Md, MD
Internal Medicine — Payments: $39,855
Internal Medicine $39,855